-Advertisement-
  About AE   About NHM   Contact Us   Terms of Use   Copyright Info   Privacy Policy   Advertising Policies   Site Map
   
Custom Search of AE Site
spacer spacer

Stemming the Tide

By Sean Henahan, Access Excellence

Norfolk, VA (7/11/01)- Stem cell researchers find themselves in the media klieg lights once again, following the release of a new study on harvesting stem cells from embryonic human cells created specifically for that purpose. This represents the latest phase in the growing debate between those favoring stem cell research for the medical benefits it might bring versus those who are strongly opposed on religious or moral grounds.

Right: Culturing Human Embyronic Stem Cells click to enlarge

The current uproar followed the release of a study in the journal Fertility & Sterility by scientists at the Jones Institute for Reproductive Medicine. The researchers reported success in creating new embryonic stem cell lines using sperm and eggs donated for that purpose. This was accomplished with private funding, since this practice is currently prohibited by federal guidelines. Current guidelines proposed by the National Institutes for Health would allow research involving human stem cells derived from human embryos, but only when the cells are derived from frozen embryos that were created for the purposes of fertility treatment, were in excess of clinical need, and were obtained after the consent of the donating couple. The NIH Guidelines also would prohibit the use of monetary inducements for the donation of the embryo.

In the case of the present, privately supported, research, eggs and sperm were provided by donors who were paid modest sums of money. Twelve donors provided 162 eggs. One hundred and ten of these were fertilized successfully, of which 50 matured to the blastocyst stage. The blastocysts yielded three viable embryonic stem cell lines. (see illustration above)

"This research demonstrates the urgent need for federal oversight of stem cell research, but federal oversight will only come hand-in-hand with federal funding," said Lawrence Soler, Chairman of the Coalition for the Advancement of Medical Research, a pro-research group.

"The job of the natural scientist is to make the discoveries; that of the technologist to develop applications; and that of the humanist is to suggest whether, how, and under what conditions the work of the other two ought to be applied. "
Werner Heim, Biologist.


This is not the first time embryos have been created specifically for research purposes. This goes back to early days of in-vitro fertilization research, long before stem cells were part of the research picture. Moreover, the practice is ongoing in other nations, notably the United Kingdom. UK researchers are entitled to funding for research of this sort provided they follow clearly established guidelines. Rather, the story is in the spotlight because it focuses the bioethical issues now being debated in Washington, DC. President GW Bush and Congress are coming come to terms with the regulation of stem cell research. On the one hand, there is considerable support for research that could lead to treatments and cures for everything from AIDS and diabetes to heart failure and Parkinson's disease. On the other hand, elements of the religious community raise moral objections to this sort of research. The current consensus seems to parallel the proposed NIH guidelines- research with stem cells left over from IVF procedures and terminated pregnancies are OK, but research with stem cells derived from embryos created specifically for that purpose crosses the ethical line. A recent ABC news poll indicated that Americans support federal funding of stem-cell research by a 2-1 margin despite controversy over its use of human embryos.

The Amazing Stem Cell

The stem cell is a remarkable type of precursor cell that carries within it the potential to differentiate into virtually any type of cell- e.g. muscle, nerve, heart - in the body. It has only been a couple of years since researchers were able to isolate and culture these cells. Stem cell research is already revealing remarkable new findings about the nature of how cells grow and differentiate to become an organism. But it is the potential for developing treatments for specific medical problems that fires the imagination of the public and the efforts of researchers. For example, a ready supply of insulin producing cells could provide a new approach to the treatment of diabetes. Similarly, stem-celled derived heart muscle cells could be a useful treatment for those with failing hearts, and a ready supply of stem-cell derived nerve-cells could offer a new hope to patients with spinal injuries.

Since pluripotent stem-cells are most plentiful in embryos, it is not surprising that many researchers are interested in that source. However, it is worth noting that stem cells of different types have also been isolated successfully from umbilical cord tissue, adult bone marrow and muscle cells. Moreover, researchers at Rockefeller University and Sloan-Kettering Institute recently announced ( in the April 27 issue of Science) that they had been able to isolate pluripotent stem cells from the tails of mice that were then induced to differentiate into viable nerve tissue. The stem cells grafted in the spinal cord, restoring movements in paralyzed mice. While the this research is in the early stages, this new direction in stem cell research could offer a way around ethical concerns (and federal regulations) on the use of stem cells derived from embryos.

Clouds on the Research Horizon

It is becoming clear that researchers have a long way to go before stem cell based therapies are available. A recent study in the journal Science (July 6, 2001) indicated that that embryonic stem cells used in cloning mice often result in severe abnormalities.This would appear to bolster the case of researchers working on tissue-specific stem cells harvested from adult sources.

'The emerging truth in the lab is that pluripotent stem cells are hard to rein in. The potential that they would explode into a cancerous mass after a stem cell transplant might turn out to be the Pandora's Box of stem cell research," noted University of Pennsylvania bioethicist Glenn McGeewas Technology Review.

What's News Index

Feedback


 
Today's Health and
BioScience News
Science Update Archives Factoids Newsmaker Interviews
Archive

 
Custom Search on the AE Site

 

-Advertisement-